Risk of Mortality among Patients with Gastrointestinal Bleeding with Early and Late Treatment with Tranexamic Acid: A Population-Based Cohort Study

Risk of Mortality among Patients with Gastrointestinal Bleeding with Early and Late Treatment with Tranexamic Acid: A Population-Based Cohort Study

Tranexamic acid (TXA) is an antifibrinolytic pharmacological agent, but its use in gastrointestinal bleeding remains contentious. Moreover, studies on the timing of TXA administration are limited. We examined whether early TXA administration reduced the risk of mortality in patients with gastrointes...

Full description

Bibliographic Details
Main Authors: Ke-Hsin Ting, Bei-Hao Shiu, Shun-Fa Yang, Pei-Lun Liao, Jing-Yang Huang, Yin-Yang Chen, Chao-Bin Yeh
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Journal of Clinical Medicine
Subjects:
tranexamic acid
gastrointestinal bleeding
mortality
thromboembolic events
Online Access:https://www.mdpi.com/2077-0383/11/6/1741

Internet

https://www.mdpi.com/2077-0383/11/6/1741

Similar Items